Medtronic Anticipates More Severe Declines in Coming Months

Medtronic's logo

Medtronic reported FY 4Q20 orthopedic revenue of USD $528.3 million, -35.1% vs. 4Q19, with full-year FY20 revenue of $2,874 million, -7.6% vs. FY19. The company’s fiscal year ended in late April and therefore includes an additional month of COVID-19 impact compared to its competitors on calendar year cycles. Procedure deferrals, over-reliance...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us